FdaApplication
ANDA 209663
Identifiers
- fda_app_no: ANDA209663
Properties
| Property | Value |
|---|---|
| applicant_name | GLENMARK SPECIALTY SA |
| application_type | ANDA |
| approval_date | 2018-11-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TERIFLUNOMIDE | TERIFLUNOMIDE | 14MG | TABLET;ORAL |
| TERIFLUNOMIDE | TERIFLUNOMIDE | 7MG | TABLET;ORAL |
2 products